Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model
Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 36 - 40 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.21004 İndeks Tarihi: 24-06-2022
Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model
Öz: Objective: Major vascular injury is one of the most important causes of death after trauma. The effective
and speedy control of the hemorrhage is crucial in reducing deaths. Many products are used for this purpose.
Today, however, an ideal product has not yet been produced and there is a strong demand for such effective
hemostatic products. The aim of this study is to compare the efficacy of Algan hemostatic agent with Floseal
in the liver laceration model in rats.
Materials and Methods: A total of 28 rats were used in the study. Rats were divided into 4 groups, each
consisting of 7 rats. Experimental liver laceration was established. In the control group, saline-impregnated
gauze was applied. Algan hemostatic agent-impregnated sponge, Algan hemostatic agent powder, and Floseal
gel were applied to the experimental groups.
Results: There was no difference in bleeding control among the Algan hemostatic agent powder, Algan
hemostatic agent-impregnated sponge, and Floseal. When compared to the control group, Algan hemostatic
agent powder, Algan hemostatic agent-impregnated sponge, and Floseal were found to be very effective in
bleeding control, respectively (P=.001, .012, and .002), in the experimental groups.
Conclusion: This study showed that the properties of both Algan hemostatic agent powder and Algan
hemostatic agent-impregnated sponge for controlling bleeding are similar to Floseal. Considering other characteristics such as Algan hemostatic agent’s naturalness, easy applicability, and low cost, Algan hemostatic
agent has been a promising effective hemostatic agent.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Parks RW, Chrysos E, Diamond T. Management of liver trauma. Br J Surg. 1999;86(9):1121-1135. [CrossRef]
- 2. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma. 2003;54(5):S13-S19. [CrossRef]
- 3. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185-193. [CrossRef]
- 4. Wu WC, Trivedi A, Friedmann PD, et al. Association between hospital intraoperative blood transfusion practices for surgical blood loss and hospital surgical mortality rates. Ann Surg. 2012;255(4):708-714. [CrossRef]
- 5. Huri E, Akgül KT, Yücel MÖ, Astarcı HM, Üstün H, Germiyanoğlu RC. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents. Turk J Med Sci. 2011;41(1):7-15.
- 6. Hanks JB, Kjaergard HK, Hollingsbee DA. A comparison of the haemostatic effect of Vivostat® patient-derived fibrin sealant with oxidised cellulose (Surgicel®) in multiple surgical procedures. Eur Surg Res. 2003;35(5):439-444. [CrossRef]
- 7. Akarsu C, Kalaycı MU, Yavuz E, et al. Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats. TJTES. 2011;17:308-312.
- 8. Aysan E, Kilic K, Kinaci E, Basak F, Caliskan YK. Efficacy of “aluminium sulphate” in prevention of hepatic parenchymal bleeding. Turk J Surg. 2004;20:147-152.
- 9. Midi A, Kumandas A, Ekici H. Investigation of the efficacy of Algan hemostatic agent in liver laceration model in rats. EJMO. 2019;3(1):37-42. [CrossRef]
- 10. Satar NYG, Akkoc A, Oktay A, Topal A, Inan K. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats. Blood Coagul Fibrinolysis. 2013;24(5):518-524. [CrossRef]
- 11. Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the Ankaferd blood stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med. 2010;3(3):186-191.
- 12. Fonouni H, Kashfi A, Majlesara A, et al. Hemostatic efficiency of modern topical sealants: comparative evaluation after liver resection and splenic laceration in a swine model. J Biomed Mater Res B Appl Biomater. 2018;106(3):1307- 1316. [CrossRef]
- 13. Ramirez MG, Deutsch H, Khanna N, Cheatem D, Yang D, Kuntze E. FloSeal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hosp Prac (1995). 2018;46(4):189-196. [CrossRef]
- 14. Coenye KE, Bourgain C, Keibl C, Nürnberger S, Griensvenet MV. A qualitative morphological comparison of two haemostatic agents in a porcine liver trauma model. Surg Sci. 2013;4(08):359-364.
- 15. Echave M, Oyagüez I, Casado MA. Use of FloSeal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review. BMC Surg. 2014;14(1):111. [CrossRef]
- 16. Saif R, Jacob M, Robinson S, et al. Use of fibrinbased sealants and gelatin-matrix hemostats in laparoscopic liver surgery. Surg Laparosc Endosc Percutan Tech. 2011;21(3):131-141. [CrossRef]
- 17. Helito CP, Bonadio MB, Sobrado MF, et al. Comparison of FloSeal® and tranexamic acid for bleeding control after total knee arthroplasty: a prospective randomized study. Clinics (Sao Paulo). 2019;74:e1186. [CrossRef]
- 18. Beyea JA, Rotenberg BW. Comparison of purified plant polysaccharide (HemoStase) versus gelatin-thrombin matrix (FloSeal) in controlling bleeding during sinus surgery: a randomized controlled trial. Ann Otol Rhinol Laryngol. 2011;120(8):495-498. [CrossRef]
- 19. Kınacı E, Basak F, Dincel O. Efficacy of calcium alginate in prevention of hepatic parenchymal bleeding: an experimental study. J Gastroenterol Hepatol. 2013;2(5):593-596.
- 20. Yasunaga H. Risk of authoritarianism: fibrinogentransmitted hepatitis C in Japan. Lancet. 2007;370(9604):2063-2067. [CrossRef]
- 21. Schwab PE, Thienpont E. Use of a haemostatic matrix (FloSeal®) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin. Blood Transfus. 2016;14(2):134-139. [CrossRef]
- 22. Midi A, Kumandaş A, Ekici H. Investigation of the effectiveness of algan hemostatic agent in renal venous bleeding model in rats. EJMI. 2018;2(3):129-132. [CrossRef]
- 23. Midi A, Ekici H, Kumandas A, et al. Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats. Marmara Med J. 2019;32(1):27-32. [CrossRef]
- 24. Midi A, Ozyurek H, Karahan S, et al. Investigation of efficacy of the plant based algan hemostatic agent in hepatectomy bleeding model in rats. EJMI. 2018;2:195-201. [CrossRef]
- 25. Aksoy H, Sener A, Akakin D, et al. The Effect of algan hemostatic agent (AHA) on wound healing. Clin Exp Health Sci. 2020;10(3):279-284. [CrossRef]
- 26. Gedar Totuk ÖM, Güzel ŞE, Ekici H, et al. Effects of algan hemostatic agent on bleeding time in a rat tail hemorrhage model. Ulus Travma Acil Cerrahi Derg. 2020;26(6):853-858. [CrossRef]
- 27. Song H, Zhang L, Zhao X. Hemostatic efficacy of biological self‐assembling peptide nanofibers in a rat kidney model. Macromol Biosci. 2010;10(1):33-39. [CrossRef]
- 28. Rhee P, Brown C, Martin M, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma. 2008;64(4):1093- 1099. [CrossRef]
- 29. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6):S3- 11. [CrossRef]
APA | BİNNETOĞLU K, KUMANDAS A, Ekici H, Ozbaykus A (2022). Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. , 36 - 40. 10.5152/eurasianjmed.2022.21004 |
Chicago | BİNNETOĞLU Kenan,KUMANDAS ALI,Ekici Hüsamettin,Ozbaykus Abdullah Canberk Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. (2022): 36 - 40. 10.5152/eurasianjmed.2022.21004 |
MLA | BİNNETOĞLU Kenan,KUMANDAS ALI,Ekici Hüsamettin,Ozbaykus Abdullah Canberk Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. , 2022, ss.36 - 40. 10.5152/eurasianjmed.2022.21004 |
AMA | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. . 2022; 36 - 40. 10.5152/eurasianjmed.2022.21004 |
Vancouver | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. . 2022; 36 - 40. 10.5152/eurasianjmed.2022.21004 |
IEEE | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A "Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model." , ss.36 - 40, 2022. 10.5152/eurasianjmed.2022.21004 |
ISNAD | BİNNETOĞLU, Kenan vd. "Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model". (2022), 36-40. https://doi.org/10.5152/eurasianjmed.2022.21004 |
APA | BİNNETOĞLU K, KUMANDAS A, Ekici H, Ozbaykus A (2022). Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine, 54(1), 36 - 40. 10.5152/eurasianjmed.2022.21004 |
Chicago | BİNNETOĞLU Kenan,KUMANDAS ALI,Ekici Hüsamettin,Ozbaykus Abdullah Canberk Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine 54, no.1 (2022): 36 - 40. 10.5152/eurasianjmed.2022.21004 |
MLA | BİNNETOĞLU Kenan,KUMANDAS ALI,Ekici Hüsamettin,Ozbaykus Abdullah Canberk Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.36 - 40. 10.5152/eurasianjmed.2022.21004 |
AMA | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine. 2022; 54(1): 36 - 40. 10.5152/eurasianjmed.2022.21004 |
Vancouver | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. Eurasian Journal of Medicine. 2022; 54(1): 36 - 40. 10.5152/eurasianjmed.2022.21004 |
IEEE | BİNNETOĞLU K,KUMANDAS A,Ekici H,Ozbaykus A "Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model." Eurasian Journal of Medicine, 54, ss.36 - 40, 2022. 10.5152/eurasianjmed.2022.21004 |
ISNAD | BİNNETOĞLU, Kenan vd. "Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model". Eurasian Journal of Medicine 54/1 (2022), 36-40. https://doi.org/10.5152/eurasianjmed.2022.21004 |